HDAC5 and neuroblastoma: Although CD9 expression could be elevated by either HDAC5 siRNA, or treatment with the HDACi panobinostat, across a number of neuroblastoma cell lines, siRNA mediated knockdown of HDACs 2, 3, and 10 elicited opposing effects on CD9 expression.